Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 7.42 -3.76% -0.29
KALA closed down 3.76 percent on Friday, March 22, 2019, on 87 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical KALA trend table...

Date Alert Name Type % Chg
Mar 22 50 DMA Support Bullish 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Lower Bollinger Band Walk Weakness 0.00%
Mar 22 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 22 Down 4 Days in a Row Weakness 0.00%
Mar 22 Down 5 Days in a Row Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%

Older signals for KALA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Medicine Medical Specialties Pain Organ Systems Macular Degeneration Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Post Surgical Ocular Inflammation
Is KALA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.07
52 Week Low 4.03
Average Volume 232,657
200-Day Moving Average 9.24
50-Day Moving Average 7.1898
20-Day Moving Average 8.3355
10-Day Moving Average 8.234
Average True Range 0.5466
ADX 28.25
+DI 18.6553
-DI 26.9171
Chandelier Exit (Long, 3 ATRs ) 7.6102
Chandelier Exit (Short, 3 ATRs ) 8.7798
Upper Bollinger Band 9.0444
Lower Bollinger Band 7.6266
Percent B (%b) -0.15
BandWidth 17.009178
MACD Line 0.1755
MACD Signal Line 0.3513
MACD Histogram -0.1758
Fundamentals Value
Market Cap 179.76 Million
Num Shares 24.2 Million
EPS -32.85
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.37
Resistance 3 (R3) 8.38 8.07 8.21
Resistance 2 (R2) 8.07 7.83 8.07 8.15
Resistance 1 (R1) 7.75 7.68 7.60 7.74 8.10
Pivot Point 7.44 7.44 7.37 7.44 7.44
Support 1 (S1) 7.12 7.20 6.97 7.11 6.74
Support 2 (S2) 6.81 7.05 6.81 6.69
Support 3 (S3) 6.49 6.81 6.63
Support 4 (S4) 6.48